Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

RNLX

Renalytix Plc ADR

Apr 18 • 04:00PM ET

0.7850

Dollar change -0.0450
Percentage change -5.42	%

Healthcare • Health Information Services • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.91	Insider Own	-	Shs Outstand	46.89M	Perf Week	-15.41%
Market Cap	49.54M	Forward P/E	-	EPS next Y	-0.48	Insider Trans	-	Shs Float	46.30M	Perf Month	-21.50%
Income	-41.85M	PEG	-	EPS next Q	-0.09	Inst Own	13.09%	Short Float	1.72%	Perf Quarter	200.77%
Sales	2.41M	P/S	20.56	EPS this Y	-5.69%	Inst Trans	-13.32%	Short Ratio	0.42	Perf Half Y	-39.15%
Book/sh	-0.16	P/B	-	EPS next Y	19.42%	ROA	-199.59%	Short Interest	0.80M	Perf Year	-67.83%
Cash/sh	0.09	P/C	8.82	EPS next 5Y	-	ROE	-9009.47%	52W Range	0.24 - 4.04	Perf YTD	101.28%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-134.94%	ROI	-	52W High	-80.56%	Beta	2.99
Dividend TTM	-	Quick Ratio	0.59	Sales past 5Y	22.75%	Gross Margin	6.31%	52W Low	220.54%	ATR (14)	0.11
Dividend Ex-Date	-	Current Ratio	0.59	EPS Y/Y TTM	20.51%	Oper. Margin	-1579.88%	RSI (14)	44.40	Volatility	9.34% 9.71%
Employees	-	Debt/Eq	-	Sales Y/Y TTM	-36.65%	Profit Margin	-1736.47%	Recom	1.00	Target Price	4.15
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	37.43%	Payout	-	Rel Volume	0.11	Prev Close	0.83
Sales Surprise	-7.14%	EPS Surprise	0.22%	Sales Q/Q	-40.52%	Earnings	Feb 15 BMO	Avg Volume	1.88M	Price	0.78
SMA20	-9.08%	SMA50	-11.88%	SMA200	-43.29%	Trades		Volume	209,438	Change	-5.42%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-18-22	Initiated	H.C. Wainwright	Buy	$30
Jan-04-22	Initiated	BTIG Research	Buy	$24
Oct-04-21	Initiated	Guggenheim	Buy	$28
Jul-02-21	Initiated	Berenberg	Buy	$38
Aug-11-20	Initiated	Stifel	Buy

Apr-08-24 07:00AM	Renalytix Announces Financing with Expected Size of up to $4 Million (GlobeNewswire)
Mar-25-24 03:58PM	3 Ridiculously Enticing Stocks to Buy for Under a Buck (InvestorPlace) -8.11%
Mar-14-24 07:00AM	KidneyIntelX included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) (GlobeNewswire) +9.19%
Feb-15-24 07:00AM	Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024 (GlobeNewswire) -35.10%
Feb-09-24 09:00AM	Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -29.61%
07:00AM	Loading…
Jan-10-24 07:00AM	New published data demonstrates KidneyIntelX has broad implications for winning war on chronic kidney disease (GlobeNewswire) -14.94%
Nov-14-23 07:00AM	Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024 (GlobeNewswire) -37.51%
Nov-07-23 07:00AM	Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14 (GlobeNewswire)
Oct-16-23 12:00PM	What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock (Zacks) +9.48%
Oct-06-23 07:00AM	US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix (GlobeNewswire) -7.52%
Oct-05-23 09:35AM	Renalytix AI PLC Sponsored ADR (RNLX) Loses -44.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -10.74%
Oct-03-23 08:45AM	Renalytix Plc (NASDAQ:RNLX) Q4 2023 Earnings Call Transcript (Insider Monkey) +7.33%
Sep-28-23 07:00AM	Renalytix Reports Full Year Fiscal 2023 Results (GlobeNewswire) -22.96%
Sep-25-23 07:00AM	Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28 (GlobeNewswire) -5.96%
Sep-07-23 07:00AM	Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer (GlobeNewswire) -6.32%
07:00AM	Loading…
Aug-03-23 07:00AM	Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd (GlobeNewswire)
Jul-21-23 07:00AM	Renalytix Announces Middle East Distribution Agreement with Vector Pharma (GlobeNewswire) +7.60%
Jul-07-23 07:00AM	Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions (GlobeNewswire) +11.15%
Jul-03-23 07:00AM	Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors (GlobeNewswire) +5.82%
Jun-29-23 06:01PM	FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease (GlobeNewswire)
Jun-15-23 07:00AM	KidneyIntelX Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences (GlobeNewswire) +9.72%
Jun-13-23 12:28PM	Renalytix Plc (NASDAQ:RNLX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Jun-05-23 07:00AM	Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9 (GlobeNewswire) -7.98%
May-25-23 07:00AM	Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes (GlobeNewswire)
Apr-19-23 07:00AM	New Published Real-World Evidence Shows KidneyIntelX Utility (GlobeNewswire)
Apr-12-23 07:00AM	Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting (GlobeNewswire)
Apr-06-23 12:24PM	Renalytix Plc (NASDAQ:RNLX) Q2 2023 Earnings Call Transcript (Insider Monkey)
Mar-22-23 07:00AM	Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30 (GlobeNewswire)
Feb-09-23 07:00AM	Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -5.14%
Feb-08-23 07:00AM	Renalytix announces a c.$20.3 million private placement (GlobeNewswire)
07:00AM	Loading…
Jan-26-23 07:00AM	Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States (GlobeNewswire)
Jan-09-23 07:00AM	Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems (GlobeNewswire) +5.53%
Dec-07-22 02:12PM	Renalytix Plc (NASDAQ:RNLX) Q1 2023 Earnings Call Transcript (Insider Monkey) -9.50%
Dec-01-22 07:00AM	Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes (GlobeNewswire)
Nov-30-22 08:30AM	Edited Transcript of RENX.L earnings conference call or presentation 30-Nov-22 1:30pm GMT (Thomson Reuters StreetEvents) +7.98%
Nov-29-22 07:00AM	Published Real World Evidence Demonstrates KidneyIntelX Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease (GlobeNewswire) +24.50%
Nov-22-22 07:00AM	Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30 (GlobeNewswire)
Nov-03-22 07:00AM	Renalytix to Present at Stifel Healthcare Conference (GlobeNewswire)
Oct-31-22 07:00AM	Renalytix Reports Full Year Fiscal 2022 Results (GlobeNewswire) +16.77%
Oct-24-22 07:00AM	Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31 (GlobeNewswire) -5.78%
Oct-17-22 07:00AM	KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology (GlobeNewswire) -8.86%
Sep-20-22 07:00AM	Renalytix Announces Change to Board of Directors (GlobeNewswire)
Sep-08-22 07:00AM	Renalytix to Present at H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-08-22 07:00AM	Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX with Primary Care Physicians (GlobeNewswire)
Jun-30-22 07:00AM	Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022 (GlobeNewswire) -38.29%
Jun-27-22 12:13PM	Momentive (MNTV) Surges 10.1%: Is This an Indication of Further Gains? (Zacks) -9.41%
Jun-23-22 07:00AM	Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30 (GlobeNewswire) +12.12%
Jun-10-22 07:00AM	1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients (GlobeNewswire) -5.35%
Jun-09-22 06:45AM	3 Penny Stocks That Wall Street Thinks Are Undervalued (InvestorPlace)
Jun-08-22 07:00AM	Renalytix to Present at 42nd Annual William Blair Growth Stock Conference (GlobeNewswire) +12.17%
Jun-06-22 07:00AM	KidneyIntelX Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort (GlobeNewswire) -13.13%
Jun-02-22 07:00AM	Renalytix Announces Two Data Presentations on KidneyIntelX at American Diabetes Association 82nd Scientific Sessions® (GlobeNewswire) +9.31%
May-12-22 01:00PM	AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors (GlobeNewswire) +7.82%
Apr-08-22 07:00AM	Renalytix plc successful completion of $30.0 million financing package (GlobeNewswire)
07:00AM	Renalytix plc Issue of shares (GlobeNewswire)
Mar-31-22 07:05AM	Renalytix announces a $30.0 million financing package (GlobeNewswire)
07:00AM	Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022 (GlobeNewswire)
Mar-30-22 07:00AM	Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors (GlobeNewswire)
Mar-29-22 07:00AM	Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes (GlobeNewswire) +17.52%
Mar-25-22 07:00AM	Renalytix to Report Second Quarter and First Half Fiscal Year 2022 Financial Results on March 31 (GlobeNewswire) -8.03%
Mar-09-22 07:00AM	Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform (GlobeNewswire)
Feb-24-22 07:00AM	KidneyIntelX Clinical Results Presented at World Congress of Nephrology Demonstrate Improved Prediction of Kidney Function Over Standard of Care (GlobeNewswire)
Feb-22-22 07:30AM	Renalytix to Present at Cowen 42nd Annual Health Care Conference (GlobeNewswire)
07:00AM	Renalytix to Appoint Timothy Scannell to Board of Directors (GlobeNewswire)
Jan-27-22 07:00AM	Renalytix to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -6.46%
Jan-20-22 07:47AM	Renalytix AI PLC Sponsored ADR (RNLX) Surges 10.4%: Is This an Indication of Further Gains? (Zacks)
Jan-11-22 08:15AM	Positive Study Results Published for KidneyIntelX in Monitoring Patient Response to New Drug Therapy (GlobeNewswire) +8.09%
Jan-10-22 07:00AM	Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast (GlobeNewswire)
Jan-07-22 07:00AM	Renalytix Appoints Jean M. Casner as Chief Human Resources Officer (GlobeNewswire)
Jan-05-22 07:00AM	Renalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare Conference (GlobeNewswire)
Jan-04-22 11:17AM	Renalytix Ends Down Slightly After ADA Joint Program and Buy Rating (Investing.com)
07:00AM	American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population (GlobeNewswire)
Dec-02-21 07:00AM	Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7 (GlobeNewswire) -5.99%
Nov-20-21 06:09AM	3 Small-Cap Stocks to Buy Now and Hold for the Long Haul (Motley Fool)
Nov-10-21 07:00AM	Renalytix Convenes Expert Panel at VA Healthcare Summit (GlobeNewswire) -6.61%
Nov-09-21 07:00AM	St. Josephs Health and Renalytix Partner to Advance Value-Based Kidney Health in New York (GlobeNewswire)
Oct-25-21 01:53PM	Heres Why Renalytix Plc (RNLX) Landed in Algers Top Detractor List (Insider Monkey)
Oct-21-21 07:00AM	Renalytix Reports Full Year Fiscal 2021 Results (GlobeNewswire) +5.59%
Oct-08-21 07:00AM	Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21 (GlobeNewswire)
Oct-07-21 07:00AM	Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals (GlobeNewswire)
06:39AM	3 Growth Stocks Wall Street Thinks Could Rise 50% or More (Motley Fool)
Sep-29-21 01:14PM	Hedge Funds Are Piling Into Renalytix Plc (RNLX) (Insider Monkey)
Sep-14-21 07:00AM	Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX Enabled Health Care Model (GlobeNewswire) -12.45%
Sep-09-21 06:03AM	3 High-Growth Healthcare Stocks to Buy in September (Motley Fool) -5.53%
Sep-03-21 07:00AM	Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference (GlobeNewswire)
Aug-30-21 07:00AM	Renalytix Appoints Daniel J. Levangie to its Board of Directors (GlobeNewswire) +11.81%
06:36AM	3 High-Growth Stocks That Could Soar by 30% or Better According to Wall Street (Motley Fool)
Aug-26-21 07:00AM	Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX Testing at Primary Care Level (GlobeNewswire) +7.36%
Aug-03-21 06:16AM	3 High-Growth Healthcare Stocks to Buy in August (Motley Fool) -5.04%
Jul-28-21 07:00AM	Renalytix Appoints Ann Berman to its Board of Directors (GlobeNewswire) +7.45%
Jul-26-21 07:00AM	Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference (GlobeNewswire)
Jul-22-21 07:00AM	Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory (GlobeNewswire)
Jul-16-21 06:19AM	3 High-Growth Stocks Truly Headed for the Moon (Motley Fool)
Jul-11-21 08:43AM	3 Top Life Science Stocks to Buy on Sale Right Now (Motley Fool)
Jun-28-21 07:00AM	KidneyIntelX Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time (GlobeNewswire)
Jun-15-21 07:00AM	Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021 (GlobeNewswire)
Jun-10-21 08:00AM	Renalytix to Report Financial Results for Fiscal Third Quarter 2021 and Provide Corporate Update (GlobeNewswire)
Jun-07-21 07:00AM	Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment (GlobeNewswire)
Jun-03-21 07:00AM	Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care (GlobeNewswire)
Jun-02-21 11:34AM	Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order (PR Newswire)

Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RNLX

Renalytix Plc ADR

Upgrade your FINVIZ experience